Finance

Beta
Lists
STOK:NASDAQ
Stoke Therapeutics Inc
$30.01
-0.37%
(-0.11) 1D
$30.01
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STOK...
Open
$30.14
High
$31.07
Low
$29.54
Mkt. cap
1.87B
Avg. vol.
525.81K
Volume
569.52K
52-wk high
$40.22
52-wk low
$10.90
EPS
-$2.83
Beta
1.17
Shares outstanding
62.28M
No. of employees
170
Open
$30.14
High
$31.07
Low
$29.54
Mkt. cap
1.87B
Avg. vol.
525.81K
Volume
569.52K
52-wk high
$40.22
52-wk low
$10.90
EPS
-$2.83
Beta
1.17
Shares outstanding
62.28M
No. of employees
170
Analyst outlook
Analyst Ratings
Based on 8 analysts giving stock ratings to STOK in the past 3 months
Strong Buy
Buy
8
Hold
0
Sell
0
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for STOK in the last 3 months.
Highest
Current $30.01
$60.00 (+99.93%)
Average
$47.83 (+59.38%)
Lowest
$38.00 (+26.62%)
News stories
From sources across the web
About Stoke Therapeutics Inc
CEO-
Employees170
Founded2014
HeadquartersBedford, Massachusetts, United States
SectorBiotechnology
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.79 / -$0.80
+1.86%beat
Revenue / Est. (USD)
6.23M / 5.13M
+21.42%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
13.82M
10.63M
1.40M
6.23M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
25.86M
37.70M
41.70M
39.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.26M
16.03M
21.15M
19.97M
Operating expense
41.12M
53.72M
62.84M
59.65M
Total operating expenses
41.12M
53.72M
62.84M
59.65M
Operating income
-27.30M
-43.09M
-61.44M
-53.42M
Other non operating income
28.00K
3.00K
-110.00K
18.00K
EBT including unusual items
-23.48M
-39.62M
-57.93M
-50.00M
EBT excluding unusual items
-23.48M
-39.62M
-57.93M
-50.00M
Income tax expense
-
-1.28M
-
-
Effective tax rate
-
3.23%
-
-
Other operating expenses
-
-
-
-
Net income
-23.48M
-38.35M
-57.93M
-50.00M
Net profit margin
-169.96%
-360.68%
-4,132.24%
-802.75%
Earnings per share
-0.40
-0.65
-0.97
-0.79
Interest and investment income
3.79M
3.47M
3.62M
3.42M
Interest expense
-3.00K
-3.00K
-3.00K
-23.00K
Net interest expenses
3.79M
3.46M
3.62M
3.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.85M
-42.65M
-61.03M
-52.98M
Gain or loss from assets sale
-
-8.00K
153.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more